PharmaShots | Incisive News in 3 Shots

Subscribe Now

Avalo

Avalo Entered into an Exclusive WW License Agreement with Apollo to Develop and Commercialize AVTX-007 (camoteskimab) for Non-Eosinophilic Asthma

Avalo Entered into an Exclusive WW License Agreement with Apollo to Develop and Commercialize AVTX-007 (camoteskimab) for Non-Eosi...

August 2, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us